Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

85.53
Delayed Data
As of 10:18am ET
 -0.07 / -0.08%
Today’s Change
63.68
Today|||52-Week Range
91.73
+2.76%
Year-to-Date
5 Best GARP Stocks Based on PEG Ratio
Dec 06 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close85.60
Today’s open85.32
Day’s range85.21 - 86.14
Volume114,168
Average volume (3 months)1,509,179
Market cap$12.1B
Dividend yield0.75%
Data as of 10:18am ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-36,609.52%
Earnings growth (this year)-3.62%
Earnings growth (next 5 years)+6.65%
Revenue growth (last year)-4.71%
P/E ratioNM
Price/Sales2.26
Price/Book2.06

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+0.46+0.33%
ALNYAlnylam Pharmaceutic...-3.75-2.87%
ALKSAlkermes Plc-0.43-0.81%
SGENSeattle Genetics Inc-5.99-10.11%
Data as of 10:33am ET, 12/11/2017

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)$1.24
Annual revenue (last year)$5.3B
Annual profit (last year)-$4.0B
Net profit margin-76.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
John T. Hendrickson
Executive VP-
Global Operations and Supply Chain
Ronald Janish
Corporate headquarters
Dublin, Dublin

Forecasts